Search

everythinglearnresearchcommunity

for

Search:↓

Higher Claudin 3 levels in the blood are linked to more severe alopecia areata.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Dermatological diseases affect women's work performance more than men's.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

People with certain skin diseases have higher levels of the hormone prolactin in their blood.

CGF therapy may effectively treat psoriasis by reducing inflammation.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

People with alopecia areata often have lower vitamin D levels than healthy people.

STS01 1% effectively promotes hair regrowth with minimal side effects.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Baricitinib is effective and safe for treating severe alopecia areata.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

COVID-19 doesn't make alopecia areata worse.

Lulican™ shampoo is more effective and better tolerated than Ketoconazole for treating scalp seborrheic dermatitis.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Oral Apremilast effectively treats alopecia areata in most patients.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Higher fiber intake may reduce psoriasis severity, but more research is needed for effective dietary strategies.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.